The Atlantic
A new study by Prof. Jeffrey Harris finds that the extensive research invested in developing a vaccine for HIV has contributed to the successful development of Covid-19 vaccines, writes Derek Thompson for The Atlantic. Nearly 90 percent of COVID-19 vaccines that made it to clinical trials used technology that “could be traced back to prototypes tested in HIV vaccine trials,” Harris found.